MedPath

A clinical trial to study the effect of topical minoxidil 5% solution alone and a combination topical minoxidil 5% and finasteride 0.1% solution for the treatment of common baldness in me

Phase 4
Conditions
Health Condition 1: null- Male pattern hair loss
Registration Number
CTRI/2017/10/010054
Lead Sponsor
Government Medical College and Hospital Sector Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients with clinical diagnosis of male pattern baldness with Modified Norwood-Hamilton grading III vertex, IV and V

2. Duration of hair loss less than 5 years

Exclusion Criteria

1. Any systemic or topical treatment for hair loss in last 6 months

2. Any significant cardiovascular diseases like coronary artery disease, congestive heart failure, cardiac dysrhythmias or valvular disease

3. Unrealistic expectations

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The three primary efficacy and safety outcome measures will be the change in total and terminal hair count, scoring of the global photographs by blinded evaluators and adverse events, assessed in both the groups <br/ ><br>Timepoint: 12 weekly <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
The secondary efficacy outcome measure will be the patients subjective hair growth assessment score.Timepoint: 12 weekly
© Copyright 2025. All Rights Reserved by MedPath